evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
19451,GENE_SUMMARY,,IKZF1 encodes a transcription factor involved in lymphocyte development. Loss-of-function alterations of IKZF1 are frequently found in B-cell acute lymphocytic leukemia.,,2017-04-17,,10320,IKZF1,IKAROS family zinc finger 1,False,ENST00000331340,ENST00000331340,CVID13,IKAROS,PRO0758,LyF-1,LYF1,Hs.54452,ZNFN1A1,IK1,PPP1R92,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
19452,GENE_BACKGROUND,,"The IKZF1 gene encodes the Ikaros family zinc finger 1 transcription factor (IKZF1). IKZF1 functions in hematopoietic stem cells to induce lymphoid specification and differentiation (PMID: 19345118, 16518393). As a transcription factor, IKZF1 alters chromatin and regulates gene expression by recruiting histone deactylases and chromatin remodeling ATPases to target genes (PMID: 10204490). IKZF1 is the target of lenalidomide induced degradation in multiple myeloma and its degradation is a key component of the drug's activity in myeloma (PMID: 24292625). IKZF1 mutations and deletions are most commonly found in B-cell acute lymphocytic leukemia (B-ALL) and may be a mechanism of leukemic transformation in Philadelphia chromosome positive (BCR-ABL) B-ALLs (PMID: 17344859, 18408710). Mutation of IKZF1 is associated with poor prognosis in B-ALL (PMID: 19129520). It is also deleted more rarely in other leukemias such as acute myeloid leukemia (PMID: 26069293, 25331116, 24072100)",,2017-04-17,,10320,IKZF1,IKAROS family zinc finger 1,False,ENST00000331340,ENST00000331340,CVID13,IKAROS,PRO0758,LyF-1,LYF1,Hs.54452,ZNFN1A1,IK1,PPP1R92,False,26069293,Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.,Haematologica,2018-09-01T20:15:00,100,9,1151-9,de Rooij JD et al,doi: 10.3324/haematol.2015.124321,,0001-09-01,,18408710,BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.,Nature,2018-05-01T20:08:00,453,7191,110-4,Mullighan CG et al,doi: 10.1038/nature06866,,0001-05-01,,19345118,Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells.,Immunity,2018-04-17T20:09:00,30,4,493-507,Ng SY et al,doi: 10.1016/j.immuni.2009.01.014,,2018-04-17T05:07:00,,17344859,Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.,Nature,2018-04-12T20:07:00,446,7137,758-64,Mullighan CG et al,,,0001-04-12,,24072100,Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.,Leukemia,2018-04-01T20:14:00,28,4,823-9,Menezes J et al,doi: 10.1038/leu.2013.283,,0001-04-01,,10204490,Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.,Immunity,0001-03-01,10,3,345-55,Kim J et al,,,0001-03-01,,16518393,Early hematopoietic lineage restrictions directed by Ikaros.,Nature immunology,2018-04-01T20:06:00,7,4,382-91,Yoshida T et al,,,0001-04-01,,25331116,EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations.,Blood,2018-01-01T20:15:00,125,True,140-3,Lavallée VP et al,doi: 10.1182/blood-2014-07-591529,,0001-01-01,,19129520,Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.,The New England journal of medicine,2018-01-29T20:09:00,360,5,470-80,Mullighan CG et al,doi: 10.1056/NEJMoa0808253,,0001-01-29,,24292625,Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.,"Science (New York, N.Y.)",2018-01-17T20:14:00,343,6168,301-5,Krönke J et al,doi: 10.1126/science.1244851,,0001-01-17,
